The development of telomerase inhibitors: The G-quartet approach

Anti-Cancer Drug Design

Volumn 14, Issue 4, 1999, Pages 327-339

  Mergny, Jean Louis ^b   Mailliet, Patrick ^a   Lavelle, François ^a   Riou, Jean François ^a   Laoui, Abdelazize ^a   Hélène, Claude ^b  

^a SANOFI   (France)

^b MUSÉUM NATIONAL D'HISTOIRE NATURELLE   (France)

Author keywords

G guartet; G4 DNA; Quadruplex; Telomerase inhibitors; Telomere

Indexed keywords

GUANINE; POLYNUCLEOTIDE; TELOMERASE; TRANSFERASE INHIBITOR;

ARTICLE; CANCER; CELL AGING; GENOME; HUMAN; HUMAN CELL; NUCLEOTIDE REPEAT; PRIORITY JOURNAL; TELOMERE;

ENZYME INHIBITORS; GUANINE; MODELS, MOLECULAR; OLIGONUCLEOTIDES, ANTISENSE; RNA, ANTISENSE; TELOMERASE; TEMPLATES, GENETIC;

EID: 0032718247     PISSN: 02669536     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (106)

1. Aboul-ela F., Murchie A.I.H., Lilley D.M.J. (1992) NMR study of parallel-stranded tetraplex formation by the hexadeoxynucleotide d(Tg4T). Nature, 360, 280.
2. Allsopp R.C., Chang E., Kashefiaazam M., Rogaev E.I., Piatyszek M.A., Shay J.W., Harley C.B. (1995) Telomere shortening is associated with cell division in vitro and in vivo. Experimental Cell Research, 220, 194.
3. Anantha N.V., Azam M., Sheardy R.D. (1998) Porphyrin binding to quadrupled T4G4. Biochemistry, 37, 2709.
4. Arthanari H., Basu S., Kawano T.L., Bolton P.H. (1998) Fluorescent dyes specific for quadruplex DNA. Nucleic Acids Research, 26, 3724.
5. Bacchetti S., Counter C. M. (1995) Telomeres and telomerase in human cancer (Review). International Journal of Oncology, 7, 423.
6. Balagurumoorthy P., Brahmachari S.K. (1994) Structure and stability of human telomeric sequence. Journal of Biological Chemistry, 269, 21858.
7. Bare L.A., Trinh L., Wu S., Devlin J.J. (1998) Identification of a series of potent telomerase inhibitors using a time-resolved fluorescence based assay. Drug Development Research, 43, 109.
8. Beattie T.L., Zhou W., Robinson M.O., Harrington L. (1998) Reconstitution of human telomerase activity in vitro. Current Biology, 8, 177.
9. Bianchi A., Smith S., Chong L., Elias P., de Lange T. (1997) TRF1 is a dimer and bends telomeric DNA. EMBO Journal, 16, 1785.
10. Bilaud T., Brun C., Ancelin K., Koering C.E., Laroche T., Gilson E. (1997) Telomeric localization of TRF2, a novel human telobox protein. Nature Genetics 17, 236.
11. Blasco M.A., Lee H.W., Hande M.P., Samper E., Lansdorp P.M., DePinho R.A., Greider C.W. (1997) Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell, 91, 25.
12. Bodnar A.G., Ouellette M., Frolkis M., Holt S.E., Chiu C.P., Morin G.B., Harley C.B., Shay J.W., Lichtsteiner S., Wright W.E. (1998) Extension of life-span by introduction of telomerase into normal human cells. Science, 279, 349.
13. Broccoli D., Smogorzewska A., Chong L., deLange T. (1997) Human telomeres contain two distinct Myb-related proteins, TRF1 and TRF2. Nature Genetics, 17, 231.
14. Burger A.M., Double J.A., Newell D.R. (1997) Inhibition of telomerase activity by cisplatin in human testicular cancer cells. European Journal of Cancer, 33, 638.
15. Chen Q., Kuntz I.D., Shafer R.H. (1996) Spectroscopic recognition of guanine dimeric hairpin quadruplexes by a carbocyanine dye. Proceedings of the National Academy of Sciences, USA, 93, 2635.
16. Chin L., Artandi S.E., Shen Q., Tam A., Lee S.L., Gottlieb G.J., Greider C.W, DePinho R.A. (1999) p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell, 97, 527.
17. Fedoroff O.Y., Salazar M., Han H., Chemeris V.V., Kerwin S.M., Hurley L.H. (1998) NMR-based model of a telomerase inhibiting coumpound bound to G-quadruplex DNA. Biochemistry, 37, 12367.
18. Feng J.L., Funk W.D., Wang S.S., Weinrich S.L., Avilion A.A., Chiu C.P., Adams R.R., Chang E., Allsopp R.C., Yu J.H., Le S.Y., West M.D., Harley C.B., Andrews W.H., Greider C.W, Villeponteau B. (1995) The RNA component of human telomerase. Science, 269, 1236.
19. Fu W.M., Begley J.G., Killen M.W., Mattson M.P. (1999) Anti-apoptotic role of telomerase in pheochromocytoma cells. Journal of Biological Chemistry, 274, 7264.
20. Gehring K., Leroy J.L., Guéron M. (1993) A tetrameric structure with protonated cytosine.cytosine base pairs. Nature, 363, 561.
21. Gomez D.E., Tejera A.M., Olivero O.A. (1998) Irreversible telomere shortening by 3′-azido-2′,3′-dideoxythymidine (AZT) treatment. Biochemistry and Biophysics Research Communications, 246, 107.
22. Greenberg R.A., Chin L., Femino A., Lee K.H., Gottlieb G.J., Singer R.H., Greider C.W., DePinho R.A. (1999) Short dysfunctional telomeres impair tumorigenesis in the INK4a(Delta 2/3) cancer-prone mouse. Cell, 97, 515.
23. Greider C.W., Blackburn E.H. (1985) Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell, 43, 405.
24. Griffith J.D., Comeau L., Rosenfield S., Stansel R.M., Bianchi A., Moss H., deLange T. (1999) Mammalian telomeres end in a large duplex loop. Cell, 97, 503.
25. Guo Q., Lu M., Marky L.A., Kallenbach N.R. (1992) Interaction of the dye ethidium bromide with DNA containing guanine repeats. Biochemistry, 31, 2451.
26. Han F.X.G., Wheelhouse R.T., Hurley L.H. (1999a) Interactions of TMPyP4 and TMPyP2 with quadruplex DNA. Structural basis for the differential effects on telomerase inhibition. Journal of the American Chemical Society, 121, 3561.
27. Han H.Y., Cliff C.L., Hurley L.H. (1999b) Accelerated assembly of G-quadruplex structures by a small molecule. Biochemistry, 38, 6981.
28. Han H.Y., Hurley L.H., Salazar M. (1999c) A DNA polymerase stop assay for G-quadruplex-interactive compounds. Nucleic Acids Research, 27, 537.
29. Haq I., Ladbury J.E., Chowdhry B.Z., Jenkins T.C. (1996) Molecular anchoring of duplex and triplex DNA by disubstituted anthracene-9,10-diones: calorimetric, UV melting, and competition dialysis studies. Journal of the American Chemical Society, 118, 10693.
30. Haq I., Trent J.O., Chowdhry B.Z., Jenkins T.C. (1999) Intercalative G-tetraplex stabilization of telomeric DNA by a cationic porphyrin. Journal of the American Chemical Society, 121, 1768.
31. Hardin C.C., Henderson E., Watson T., Prosser J.K. (1991) Monovalent cation induced structural transitions in telo-meric DNAs: G-DNA folding intermediates. Biochemistry, 30, 4460.
32. Hastie N.D., Dempster M., Dunlop M.G., Thompson A.M., Green D.K., Allshire R.C. (1990) Telomere reduction in human colorectal carcinoma and with ageing. Nature, 346, 866.
33. Henderson E., Hardin C.C., Walk S.K., Tinoco I. Jr, Blackburn E.H. (1987) Telomeric DNA oligonucleotides form novel intramolecular structures containing guanine-guanine base pairs. Cell, 51, 899.
34. Herrera E., Samper E., Martin-Caballero J., Flores J.M., Lee H.W., Blasco M.A. (1999) Disease states associated with telomerase deficiency appear earlier in mice with short telomeres. EMBO Journal, 18, 2950.
35. Holt S.E., Aisner D.L., Baur J., Tesmer V.M., Dy M., Ouellette M., Trager J.B., Morin G.B., Toft D.O., Shay J.W., Wright W.E., White M.A. (1999) Functional requirement of p23 and Hsp90 in telomerase complexes. Genes Development, 13, 817.
36. Ishibashi T., Lippard S.J. (1998) Telomere loss in cells treated with cisplatin. Proceedings of the National Academy of Sciences, USA, 95, 4219.
37. Izbicka E., Wheelhouse R.T., Raymond E., Davidson K.K., Lawrence R.A., Sun D.Y., Windle B.E., Hurley L.H., VonHoff D.D. (1999) Effects of cationic porphyrins as G-quadruplex interactive agents in human tumor cells. Cancer Research, 59, 639.
38. Jin R.Z., Gaffney B.L., Wang C., Jones R.A., Breslauer K.J. (1992) Thermodynamics and structure of a DNA tetraplex - a spectroscopic and calorimetric study of the tetramolecular complexes of d(TG3T) and d(TG3T2G3T). Proceedings of the National Academy of Sciences, USA, 89, 8832.
39. Kang C.H., Zhang X., Ratliff R., Moyzis R., Rich A. (1992) Crystal structure of four-stranded Oxytricha telomeric DNA. Nature, 356, 126.
40. Karlseder J., Broccoli D., Dai Y.M., Hardy S., deLange T. (1999) p53-And ATM-dependent apoptosis induced by telomeres lacking TRF2. Science, 283, 1321.
41. Kawakami M., Koya K., Ukai T., Tatsuka N., Ikegawa A., Ogawa K., Shishido T., Chen L.B. (1998) Structure-activity of novel rhodacyanine dyes as antitumor agents. Journal of Medicinal Chemistry, 41, 130.
42. Kilian A., Bowtell D.D.L., Abud H.E., Hime G.R., Venter D.J., Keese P.K., Duncan E.L., Reddel R.R., Jefferson R.A. (1997) Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. Human Molecular Genetics, 6, 2011.
43. Kim N.W., Piatyszek M.A., Prowse K.R., Harley C.B., West M.D., Ho P.L.C., Coviello G.M., Wright W.E., Weinrich S.L., Shay J.W. (1994) Specific association of human telomerase activity with immortal cells and cancer. Science, 266, 2011.
44. Kipling D., Wynford Thomas D., Jones C.J., Akbar A., Aspinall R., Bacchetti S., Blasco M.A., Broccoli D., DePinho R.A., Edwards D.R., Effros R.B., Harley C.B., Lansdorp P.M., Linskens M.H.K., Prowse K.R., Newbold R.F., Olovnikov A.M., Parkinson E.K., Pawelec G., Ponten J., Shall S., Zijlmans M., Faragher R.G.A. (1999) Telomere-dependent senescence. Nature Biotechnology, 17, 313.
45. Kondo S., Kondo Y., Li G., Silverman R.H., Cowell J.K. (1998a) Targeted therapy of human malignant glioma in a mouse model by 2-5A antisense directed against telomerase RNA. Oncogene, 16, 3323.
46. Kondo S., Tanaka Y, Kondo Y., Hitomi M., Barnett G.H., Ishizaka Y., Liu J., Haqqi T., Nishiyama A., Villeponteau B., Cowell J.K., Barna B.P. (1998b) Antisense telomerase treatment: induction of two distinct pathways, apoptosis and differentiation. FASEB Journal, 12, 801.
47. Ku W.C., Cheng A.J., Wang T.C.V. (1997) Inhibition of telomerase activity by PKC inhibitors in human nasopharyngeal cancer cells in culture. Biochemistry and Biophysics Research Communications, 241, 730.
48. La Branche H., Dupuis S., Ben-David Y., Bani M.R., Wellinger R.J., Chabot B. (1998) Telomere elongation by hnRNP A1 and a derivative that interacts with telomeric repeats and telomerase. Nature Genetics, 19, 199.
49. Laughlan G., Murchie A.I.H., Norman D.G., Moore M.H., Moody P.C.E., Lilley D.M.J., Luisi B. (1994) The high-resolution crystal structure of a parallel-stranded guanine tetraplex. Science, 265, 520.
50. Lee H.W., Blasco M.A., Gottlieb G.J., Horner J.W. II, Greider C.W., DePinho R.A. (1998) Essential role of mouse telomerase in highly proliferative organs. Nature, 392, 569.
51. Li H., Zhao L.L., Funder J.W., Liu J.P. (1997) Protein phosphatase 2A inhibits nuclear telomerase activity in human breast cancer cells. Journal of Biological Chemistry, 272, 16729.
52. Liu K.B., Schoonmaker M.M., Levine B.L., June C.H., Hodes R.J., Weng R.P. (1999) Constitutive and regulated expression of telomerase reverse transcriptase (HTERT) in human lymphocytes. Proceedings of the National Academy of Sciences, USA, 96, 5147.
53. Lu M., Guo Q., Kallenbach N.R. (1992) Structure and stability of sodium and potassium complexes of dT4G4 and dT4G4T. Biochemistry, 31, 2455.
54. Lu M., Guo Q., Kallenbach N.R. (1993) Thermodynamics of G-tetraplex formation by telomeric DNAs. Biochemistry, 32, 598.
55. Makarov V.L., Hirose Y., Langmore J.P. (1997) Long G tails at both ends of human chromosomes suggest a C strand degradation mechanism for telomere shortening. Cell, 88, 657.
56. Mata J.E., Joshi S.S., Palen B., Pirruccello S.J., Jackson J.D., Elias N., Page T.J., Medlin K.L., Iversen P.L. (1997) A hexameric phosphorothioate oligonucleotide telomerase inhibitor arrests growth of Burkitt's lymphoma cells in vitro and in vivo. Toxicology and Applied Pharmacology, 144, 189.
57. Matthes E., Lehmann C. (1999) Telomerase protein rather than its RNA is the target of phosphorothioate-modified oligonucleotides. Nucleic Acids Research, 27, 1152.
58. Mergny J.L., Duval-Valentin G., Nguyen C.H., Perrouault L., Faucon B., Rougée M., Montenay-Garestier T., Bisagni E., Hélène C. (1992) Triple helix specific ligands. Science, 256, 1691.
59. Mergny J.L., Phan A.T., Lacroix L. (1998) Following G-quartet formation by UV-spectroscopy. FEBS Letters, 435, 74.
60. Meyerson M., Counter C.M., Eaton E.N., Ellisen L.W., Steiner P., Caddle S.D., Ziaugra L., Beijersbergen R.L., Davidoff M.J., Liu Q.Y., Bacchetti S., Haber D.A., Weinberg R.A. (1997) hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell, 90, 785.
61. Miura T., Thomas G.J. (1995) Structure and dynamics of intèrstrand guanine association in quadruplex telomeric DNA. Biochemistry, 34, 9645.
62. Mondello C., Petropoulou C., Monti D., Gonos E.S., Franceschi C., Nuzzo F. (1999) Telomere length in fibroblasts and blood cells from healthy centenarians. Experimental Cell Research, 248, 234.
63. Nakamura T.M., Morin G.B., Chapman K.B., Weinrich S.L., Andrews W.H., Lingner J., Harley C.B., Cech T.R. (1997) Telomerase catalytic subunit homologs from fission yeast and human. Science, 277, 955.
64. Nakayama J., Saito M., Nakamura H., Matsuura A., Ishikawa F. (1997) TLP1: a gene encoding a protein component of mammalian telomerase is a novel member of WD repeats family. Cell, 88, 875.
65. Nakayama J.I., Tahara H., Tahara E., Saito M., Ito K., Nakamura H., Nakanishi T., Tahara E., Ide T., Ishikawa F. (1998) Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nature Genetics, 18, 65.
66. Norton J.C., Piatyszek M.A., Wright W.E., Shay J.W., Corey D.R. (1996) Inhibition of human telomerase activity by peptide nucleic acids. Nature Biotechnology, 14, 615.
67. Nugent C.I., Bosco G., Ross L.O., Evans S.K., Salinger A.P., Moore J.K., Haber J.E., Lundblad V. (1998) Telomere maintenance is dependent on activities required for end repair of double-strand breaks. Current Biology, 8, 657.
68. Olovnikov A.M. (1973) A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. Journal of Theoretical Biology, 41, 181.
69. Pai R.B., Pai B., Kukhanova M. (1998) Telomerase from human leukemic cells: properties and its interaction with deoxynucleotide analogs. Cancer Research, 58, 1909.
70. Perry P.J., Kelland L.R. (1998) Telomeres and telomerase: targets for cancer chemotherapy? Expert Opinions in Therapeutic Patents, 8, 1567.
71. Perry P.J., Reszka A.P., Wood A.A., Read M.A., Gowan S.M., Dosanjh H.S., Trent J.O., Jenkins T.C., Kelland L.R., Neidle S. (1998) Human telomerase inhibition by regioisomeric disubstituted amidoanthracene-9,10-diones. Journal of Medicinal Chemistry, 41, 4873.
72. Pitts A.E., Corey D.R. (1998) Inhibition of human telomerase by 2′-O-methyl-RNA. Proceedings of the National Academy of Sciences, USA, 95, 11549.
73. Pitts A.E., Corey D.R. (1999) The telomerase challenge - an unusual problem in drug discovery. Drug Discovery Today, 4, 155.
74. Pooga M., Soomets U., Hallbrink M., Valkna A., Saar K., Rezaei K., Kahl U., Hao J.X., Xu X.J., Wiesenfeld Hallin Z., Hokfelt T., Bartfai A., Langel U. (1998) Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo. Nature Biotechnology, 16, 857.
75. Ramakrishnan S., Eppenberger U., Mueller H., Shinkai Y., Narayanan R. (1998) Expression profile of the putative catalytic subunit of the telomerase gene. Cancer Research, 58, 622.
76. Rudolph K.L., Chang S., Lee H.W., Blasco M., Gottlieb G.J., Greider C., DePinho R.A. (1999) Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell, 96, 701.
77. Sato N., Mizumoto K., Kusumoto M., Niiyama H., Maehara N., Ogawa T., Tanaka M. (1998) 9-Hydroxyellipticine inhibits telomerase activity in human pancreatic cancer cells. FEBS Letters, 441, 318.
78. Sen D., Gilbert W. (1988) Formation of parallel four-stranded complexes by guanine-rich motifs in DNA and its applications for meiosis. Nature, 334, 364.
79. Shafer R/H. (1998) Stability and structure of model DNA triplexes and quadruplexes and their interactions with small ligands. In Progress in Nucleic Acid Research. Moldave, K. (ed.), Vol. 59, p. 55. Academic Press: San Diego, CA.
80. Sharma S., Raymond E., Soda H., Sun D., Hilsenbeck S.G., Sharma A., Izbicka E., Windle B., von Hoff D.D. (1997) Preclinical and clinical strategies for development of telomerase and telomere inhibitors. Annals of Oncology, 8, 1063.
81. Shay J.W. (1995) Aging and cancer: are telomeres and telomerase the connection? Molecular Medicine Today, 1, 378.
82. Smith F.W., Feigon J. (1992) Quadruplex structure of Oxytricha telomeric DNA oligonucleotides. Nature, 356, 164.
83. Smith S., deLange T. (1997) TRF1, a mammalian telomeric protein. Trends in Genetics 13, 21.
84. Spackova N., Berger I., Sponer J. (1999) Nanoseconds molecular dynamics simulations of parallel and anti-parallel guanine quadruplex DNA molecules. Journal of the American Chemical Society, 121, 5519.
85. Sun D., Thompson B., Cathers B.E., Salazar M., Kerwin S.M., Trent J.O., Jenkins T.C., Neidle S., Hurley L.H. (1997) Inhibition of human telomerase by a G-quadruplex-interactive compound. Journal of Medicinal Chemistry, 40, 2113.
86. Sun H., Karow J.K., Hickson I.D., Maizels N. (1998) The Bloom's syndrome helicase unwinds G4 DNA. Journal of Biological Chemistry, 273, 27587.
87. Sun D., Lopez-Guajardo C.C., Quada J., Hurley L.H., Von Hoff D.D. (1999a) Regulation of catalytic activity and processivity of human telomerase. Biochemistry, 38, 4037.
88. Sun H., Bennett R.J., Maizels N. (1999b) The Saccharomyces cerevisiae Sgs1 helicase efficiently unwinds G-G paired DNAs. Nucleic Acids Research, 21, 1978.
89. Sundquist W.I., Klug A. (1989) Telomeric DNA dimerizes by formation of guanine tetrads between hairpin loops. Nature, 342, 825.
90. Tao M., Wada A., Takai K., Takaku H. (1998) Inhibition of telomerase activity by antisense oligonucleotides in HeLa cells. Nucleic Acids Symposium Series, 39, 85.
91. van Steensel B., de Lange T. (1997) Control of telomere length by the human telomeric protein TRF1. Nature, 385, 740.
92. van Steensel B., Smogorzewska A., de Lange T. (1998) TRF2 protects human telomeres from end-to-end fusions. Cell, 92, 401.
93. Vaziri H., Schachter F., Uchida I., Wei L., Zhu X.M., Effros R., Cohen D., Harley C.B. (1993) Loss of telomeric DNA during aging of normal and trisomy-21 human lymphocytes. American Journal of Human Genetics, 52, 661.
94. Wang Y., Patel D.J. (1992) Guanine residues in d(T2AG3) and d(T2G4) form parallel-stranded potassium cation stabilized G-quadruplexes with antiglycosidic torsion angles in solution. Biochemistry, 31, 8112.
95. Wang Y., Patel D.J. (1993) Solution structure of the human telomeric repeat d[AG3(T2AG3))3] G-tetraplex. Structure, 1, 263.
96. Wang Y., Patel D.J. (1995) Solution structure of the Oxytricha telomeric repeat d[G(4) (T(4)G(4)) (3)] G-tetraplex. Journal of Molecular Biology, 251, 76.
97. Weinrich S.L., Pruzan R., Ma L., Ouellette M., Tesmer V.M., Holt S.E., Bodnar A.G., Lichtsteiner S., Kim N.W., Trager J.B., Taylor R.D., Carlos R., Andrews W.H., Wright W.E., Shay J.W., Harley C.B., Morin G.B. (1997) Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nature Genetics, 17, 498.
98. Wheelhouse R.T., Sun D., Han H., Han E.X., Hurley L.H. (1998) Cationic porphyrins as telomerase inhibitors: the interaction of tetra (Af-methyl-4-pyridyl) porphyrin with quadruplex DNA. Journal of the American Chemical Society, 120, 3261.
99. Williamson J.R., Raghuraman M.K., Cech T.R. (1989) Monovalent cation induced structure of telomeric DNA: the G-quartet model. Cell, 59, 871.
100. Yi X.M., Tesmer V.M., SavreTrain I., Shay J.W., Wright W.E. (1999) Both transcriptional and posttranscriptional mechanisms regulate human telomerase template RNA levels. Molecular and Cellular Biology, 19, 3989.
101. Yokoyama Y., Takahashi Y., Shinohara A., Lian Z.L., Wan X.Y., Niwa K., Tamaya T. (1998) Attenuation of telomerase activity by a hammerhead ribozyme targeting the template region of telomerase RNA in endometrial carcinoma cells. Cancer Research, 58, 5406.
102. Yoon H.J., Choi I.Y., Kang M.R., Kim S.S., Muller M.T., Spitzner J.R., Chung I.K. (1998) DNA topoisomerase II cleavage of telomeres in vitro and in vivo. Bba Gene Structure and Expression, 1395, 110.
103. Yukiro M., Soichi Y. (1998) Telomerase Activity Reducer, patent JP10298079. Dai Ichi Seiyaku: Japan.
104. Zahler A.M., Williamson J.R., Cech T.R., Prescott D.M. (1991) Inhibition of telomerase by G-quartet DNA structures. Nature, 350, 718.
105. Zakian V.A. (1995) Telomeres: beginning to understand the end. Science, 270, 1601.
106. Zhu J.Y., Wang H., Bishop J.M., Blackburn E.H. (1999) Telomerase extends the lifespan of virus-transformed human cells without net telomere lengthening. Proceedings of the National Academy of Sciences, USA, 96, 3723.